Helicobacter pylori nanoparticles as a potential treatment of conventional multiple sclerosis

被引：13

作者：

Pezeshki, Mohammad Zakaria ^{[1
]}

Zarrintan, Sina ^{[2
]}

Zarrintan, Mohammad Hossein ^{[3
]}

机构：

[1] Tabriz Univ Med Sci, Fac Med, Dept Community Med, Tabriz, Iran

[2] Tabriz Univ Med Sci, Student Res Ctr, Tabriz, Iran

[3] Tabriz Univ Med Sci, Dept Pharmaceut, Sch Pharm, Tabriz, Iran

来源：

MEDICAL HYPOTHESES | 2008年 / 70卷 / 06期

关键词：

D O I：

10.1016/j.mehy.2007.12.008

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：1223 / 1223

页数：1

共 5 条

[1] Nanotechnology: A Focus on Nanoparticles as a Drug Delivery System [J].

Kingsley, Jeffrey D. ;

Dou, Huanyu ;

Morehead, Justin ;

Rabinow, Barrett ;

Gendelman, Howard E. ;

Destache, Christopher J. .

JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2006, 1 (03) :340-350

[2] Multiple sclerosis in the Japanese population [J].

Kira, J .

LANCET NEUROLOGY, 2003, 2 (02) :117-127

[3] Helicobacter pylori infection is a potential protective factor against conventional multiple sclerosis in the Japanese population [J].

Li, Wei ;

Minohara, Motozumi ;

Su, Jen Jen ;

Matsuoka, Takeshi ;

Osoegawa, Manabu ;

Ishizu, Takaaki ;

Kira, Jun-ichi .

JOURNAL OF NEUROIMMUNOLOGY, 2007, 184 (1-2) :227-231

[4] Immunology of multiple sclerosis [J].

Pender, Michael P. ;

Greer, Judith M. .

CURRENT ALLERGY AND ASTHMA REPORTS, 2007, 7 (04) :285-292

[5] Immunology of multiple sclerosis [J].

Sospedra, M ;

Martin, R .

ANNUAL REVIEW OF IMMUNOLOGY, 2005, 23 :683-747

← 1 →